New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
08:04 EDTARNAArena Pharmaceuticals to receive $500K milestone paument from Eisai
Arena Pharmaceuticals will receive a milestone payment of $500K from Eisai Laboratorios Ltda., a subsidiary of Eisai Inc., related to the filing of a marketing authorization for Belviq as a treatment for chronic weight management with the Brazilian Health Surveillance Agency.
News For ARNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent ARNA news | >>
January 23, 2015
05:57 EDTARNAStocks with implied volatility below IV index mean; ORCL ARNA
Subscribe for More Information
January 22, 2015
16:15 EDTARNAArena Pharmaceuticals initiated with a Sector Perform at RBC Capital
05:56 EDTARNAStocks with implied volatility below IV index mean; BBRY ARNA
Subscribe for More Information
January 21, 2015
09:16 EDTARNAOn The Fly: Pre-market Movers
Subscribe for More Information
09:10 EDTARNAArena Pharmaceuticals 21M share Spot Secondary priced at $5.00
Subscribe for More Information
08:51 EDTARNAArena Pharma sells 21M shares to Leucadia's Jefferies and Piper Jaffray
Arena Pharmaceuticals (ARNA) has sold 21M shares of common stock to Jefferies, a subsidiary of Leucadia (LUK) and to Piper Jaffray (PJC) as underwriters for its previously announced public offering. The offering is expected to close on or about January 26. In addition, Arena has granted the underwriters a 30-day option to purchase up to an aggregate of 3M additional shares of common stock. Arena anticipates using the net proceeds from the offering for the clinical and preclinical development of drug candidates, for discovery research for new drug candidates, and for general corporate purposes.
05:58 EDTARNAStocks with implied volatility below IV index mean; BBRY ARNA
Subscribe for More Information
January 20, 2015
18:30 EDTARNAOn The Fly: After Hours Movers
Subscribe for More Information
17:19 EDTARNAArena Pharmaceuticals cash, cash equivalents as of Dec. 31 $163.2M
Subscribe for More Information
16:05 EDTARNAArena Pharmaceuticals files to sell common stock, no amount given
Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering.
09:10 EDTARNAArena sees Q4 Belviq sales down 35%-45% vs. Q3
Subscribe for More Information
06:08 EDTARNAStocks with implied volatility below IV index mean; BBRY ARNA
Subscribe for More Information
January 16, 2015
06:10 EDTARNAStocks with implied volatility below IV index mean; BBRY ARNA
Stocks with implied volatility below IV index mean; BlackBerry (BBRY) 63, Arena Pharmaceuticals (ARNA) 86 according to iVolatility.
January 15, 2015
06:04 EDTARNAStocks with implied volatility below IV index mean; ORCL ARNA
Subscribe for More Information
January 14, 2015
10:21 EDTARNAOptions with decreasing implied volatility
Subscribe for More Information
06:03 EDTARNAStocks with implied volatility below IV index mean; ORCL ARNA
Subscribe for More Information
January 13, 2015
06:02 EDTARNAStocks with implied volatility below IV index mean; ARNA LINE
Subscribe for More Information
January 12, 2015
10:24 EDTARNAOptions with increasing implied volatility
Options with increasing implied volatility: TLM GREK ARNA AVP
08:02 EDTARNAArena Pharmaceuticals initiates Phase 2 clinical trial evaluating ralinepag
Arena Pharmaceuticals announced the initiation of patient dosing in a Phase 2 clinical trial of ralinepag, an oral, non-prostanoid prostacyclin receptor agonist intended for the treatment of pulmonary arterial hypertension. This 22-week, randomized, double-blind and placebo-controlled Phase 2 trial will evaluate the hemodynamic and exercise capacity effects, safety and tolerability of ralinepag in up to 60 patients with PAH. During the first nine weeks of the trial, patients will be titrated to their individual tolerance level, and then sustained at this level for the remainder of the trial.
06:14 EDTARNAStocks with implied volatility below IV index mean; ARNA LINE
Subscribe for More Information
1 | 2 | all recent ARNA news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use